Recent Research from Mayo Clinic Highlight Findings in Giant Cell Arteritis (Relapse Risk and Safety of Long-term Tocilizumab Use Among Patients With Giant Cell Arteritis: a Single-enterprise Cohort Study)

Source :: Immunotherapy Weekly. March 6, 2024, 5117
Publication Year :: 2024
Abstract: 2024 MAR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on Vascular Diseases and Conditions - Giant Cell Arteritis. According to [...]

Subjects :: Care and treatment
Research
Reports
Safety and security measures
Tocilizumab -- Research
Temporal arteritis -- Care and treatment -- Research
Immunotherapy -- Reports -- Research -- Safety and security measures
Vascular diseases -- Research -- Care and treatment
Giant cell arteritis -- Care and treatment -- Research
Blood circulation disorders -- Research -- Care and treatment

Tools